IL10 and cancer: The use of specific anti-IL-10 antibodies is a successful approach to show the relevance of IL-10 during hindlimb reperfusion after femoral artery ligation [20], chronic inflammation [21], certain types of cancer [22,23], and neuropathic pain [24].